These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 25975096)

  • 1. 293FT is a highly suitable mammalian cell line for the in vitro enzymatic activity analysis of typical P450 proteins.
    Dai DP; Geng PW; Cai J; Wang SH; Nic JJ; Hu JH; Hu GX; Cai JP
    Pharmazie; 2015 Jan; 70(1):33-7. PubMed ID: 25975096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of the allelic variants of cytochrome P450.
    Hiratsuka M
    Drug Metab Pharmacokinet; 2012; 27(1):68-84. PubMed ID: 22041138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
    Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
    Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous expression of high-activity cytochrome P450 in mammalian cells.
    Kumondai M; Hishinuma E; Gutiérrez Rico EM; Ito A; Nakanishi Y; Saigusa D; Hirasawa N; Hiratsuka M
    Sci Rep; 2020 Aug; 10(1):14193. PubMed ID: 32843676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression.
    Temesvári M; Kóbori L; Paulik J; Sárváry E; Belic A; Monostory K
    J Pharmacol Exp Ther; 2012 Apr; 341(1):294-305. PubMed ID: 22262920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies.
    Satoh D; Iwado S; Abe S; Kazuki K; Wakuri S; Oshimura M; Kazuki Y
    PLoS One; 2017; 12(10):e0187072. PubMed ID: 29065189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct assessment of promoter activity of human cytochrome p450 genes using optimized transfection in vitro and in vivo.
    Al-Dosari M; Zhang G; Knapp JE; Liu D
    Biosci Rep; 2006 Jun; 26(3):217-29. PubMed ID: 16850252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro tool to assess cytochrome P450 drug biotransformation-dependent cytotoxicity in engineered HepG2 cells generated by using adenoviral vectors.
    Lahoz A; Vilà MR; Fabre M; Miquel JM; Rivas M; Maines J; Castell JV; Gómez-Lechón MJ
    Toxicol In Vitro; 2013 Jun; 27(4):1410-5. PubMed ID: 22910125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism.
    Lin J; Schyschka L; Mühl-Benninghaus R; Neumann J; Hao L; Nussler N; Dooley S; Liu L; Stöckle U; Nussler AK; Ehnert S
    Arch Toxicol; 2012 Jan; 86(1):87-95. PubMed ID: 21735230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dimethyl sulfoxide on the function of cytochrome P450 2D6 in HepG2 cells upon the co-expression with NADPH-cytochrome P450 reductase.
    Narimatsu S; Takatsu N; Yamano S; Inoue Y; Hanioka N; Kiryu K; Naito S; Gonzalez FJ; Yamamoto S
    Chem Biol Interact; 2006 Jan; 159(1):47-57. PubMed ID: 16214121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract.
    Yang SP; Raner GM
    Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved proline-rich sequence between the N-terminal signal-anchor and catalytic domains is required for assembly of functional cytochrome P450 2C2.
    Chen CD; Doray B; Kemper B
    Arch Biochem Biophys; 1998 Feb; 350(2):233-8. PubMed ID: 9473296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of 32 CYP2C9 allelic variants.
    Niinuma Y; Saito T; Takahashi M; Tsukada C; Ito M; Hirasawa N; Hiratsuka M
    Pharmacogenomics J; 2014 Apr; 14(2):107-14. PubMed ID: 23752738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5.
    Wiercinska P; Squires EJ
    Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro.
    Muschler E; Lal J; Jetter A; Rattay A; Zanger U; Zadoyan G; Fuhr U; Kirchheiner J
    Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):374-9. PubMed ID: 19614891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression.
    Genovese S; Epifano F; Curini M; Menger D; Zembruski NC; Weiss J
    Phytomedicine; 2011 May; 18(7):586-91. PubMed ID: 21112752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of human hepatocytes to investigate drug metabolism and CYP enzyme induction.
    Klieber S; Torreilles F; Guillou F; Fabre G
    Methods Mol Biol; 2010; 640():295-308. PubMed ID: 20645059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
    Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
    Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.